news on tirzepatide Compounded vs. Zepbound – Forbes Health Tirzepatide vs. semaglutide: Study compares

This medication may be teratogenic and can cause birth defects

Buy Alluvi Retatrutide BPC-157 & TB-500 40mg Frequently Asked Questions 1

Powder gives the pharmacy a longer beyond-use date on the unmixed vial

Check out this review article that does a great job summarizing and synthesizing the data so far Amini 2025, No association: Abbass 2025, TriNetX: Chou 2025, TriNetX: Silverii 2024, meta-analysis of RCTs: Maro 2024, Sentinel: Increased association between semaglutide and NAION: Hathaway 2024: Simonsen 2024: Grausland 2024: My synthesis Takeaways: Pathophys seems to be related to vasodilation due to glucose control, leading to venous congestion, capillary leak, and edema ("compartment syndrome") Most data is on semaglutide, not tirzepatide, but presumed pathophys applies to the drug class Type 2 diabetes, OSA, and "disc at risk" status are additional risk factors Data is inconsistent on whether risk of NAION is increased for people taking #GLP1s for #obesity My clinical practice: For people with obesity, I'm paying attention but I'm not concerned For people with #diabetes, I'm careful to avoid rapid glucose correction and I ask their ophthalmologist to comment whether patient has a "disc-at-risk" (ie, small optic disc to cup ratio)